Chitosan-Alginate Sponge: Preparation and Application in Curcumin Delivery for Dermal Wound Healing in Rat by Dai, Mei et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 595126, 8 pages
doi:10.1155/2009/595126
Research Article
Chitosan-Alginate Sponge: Preparation and Application in
CurcuminDelivery for Dermal Wound Healingin Rat
Mei Dai,XiuLingZheng, Xu Xu, XiangYeKong, XingYi Li, GangGuo, FengLuo,
XiaZhao, Yu QuanWei,and Zhiyong Qian
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University,
Chengdu 610041, China
Correspondence should be addressed to Zhiyong Qian, anderson-qian@163.com
Received 21 June 2009; Accepted 1 September 2009
Recommended by Jeﬀrey Hughes
A biodegradable sponge, composed of chitosan (CS) and sodium alginate (SA), was successfully obtained in this work. The sponge
wasethereal andpliable.Thechemical structureandmorphologyofthesponges was characterized byFTIRandSEM.Theswelling
ability,invitrodrugreleaseanddegradationbehaviors,andaninvivoanimaltestwereemployedtoconﬁrmtheapplicabilityofthis
sponge as a wound dressing material. As the chitosan content in the sponge decreased, the swelling ability decreased. All types of
the sponges exhibited biodegradable properties. The release of curcumin from the sponges could be controlled by the crosslinking
degree. Curcumin could be released from the sponges in an extended period for up to 20 days. An in vivo animal test using SD rat
showed that sponge had better eﬀect than cotton gauze, and adding curcumin into the sponge enhanced the therapeutic healing
eﬀect.
Copyright © 2009 Mei Dai et al. Thisisanopenaccess articledistributedundertheCreativeCommonsAttributionLicense,which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
The process of wound healing is a set of coordinated
responses to tissue injury that results in tissue contraction,
closure, and restoration. The longer it takes for spontaneous
wound healing, the worse the outcome usually is, with
increasing likelihood of developing hypertrophic scarring
and unsightly alterations in pigmentation. Moreover, under
unfavorable conditions, the self-perpetuating inﬂammatory
cascade may result in increasing tissue destruction and
necrosis rather than healing [1]. The healing process can be
thought of as occurring in ﬁve phases, namely, inﬂammation
leading to haemostasis and clot formation, ﬁbroplasia and
neovascularization, formation of granulation tissue, reep-
ithelialization, and ﬁnally the formation of new extracel-
lular matrix and tissue remodeling [2]. Inﬂammation is
closelyassociatedwiththereleaseofinﬂammatorymediators
including Reactive Oxygen Species (ROS), Reactive Nitrogen
Species (RNS), along with their derivatives. These radicals
willresultinoxidativestressleadingtolipidperoxidationand
ultimately cause local and distant pathophysiological eﬀects.
However, topical applications of compounds with antioxida-
tive properties using proper materials and antioxidants will
be useful against oxidative damage and be helpful to the
healing of the wound.
Chitosan and alginate are well known for accelerating the
healingofwoundsinhumans[3,4].Chitosan(CS),anatural
cationic polymer, is biologically renewable, biodegradable,
biocompatible, nonantigenic, nontoxic, and biofunctional,
and it can accelerate the wound healing process enhancing
the functions of inﬂammatory cells, macrophages, and
ﬁbroblasts [3, 5, 6]. Alginate, an anionic polymer, also
is biocompatible, hydrophilic, and biodegradable under
normal physiological conditions. It is able to maintain
a physiologically moist microenvironment that promotes
healing and the formation of granulation tissue and achieves
hemostasis [7]. In this study, we used these two kinds
of polymer to form complexes through chemical binding.
After lyophilization, which creates the porous structure, the
sponge formed to act as a topical applications matrix.
In this work, curcumin as a multifunctional agent
was incorporated into the chitosan and alginate sponge2 Journal of Biomedicine and Biotechnology
(CA sponge) to deter wound infection. Curcumin (diferu-
loylmethane) is an orange-yellow component of turmeric
(Curcuma longa), a spice often found in curry powder [8].
It has been shown to exhibit numerous activities. Various
preclinical cell culture and animal studies suggest that
curcumin has potential because of its pharmacological prop-
erties including anti-inﬂammatory [9, 10], antimicrobial
[11], antiviral [12, 13], anticancer [14], antioxidant [15–17],
chemosensitizer[18,19],radiosensitizer[20,21],andwound
healing activities [22–24]. Topical applications of curcumin
with its properties of anti-inﬂammatory antioxidant (free
radical scavenging activity), induction of detoxiﬁcation
enzymes, and providing protection against degenerative
disease in patients have shown to improve signiﬁcantly
wound healing and protect tissues from oxidative damage
[24].
2.MaterialsandMethods
2.1.Materials. Chitosan(Mw300,000anddegreeofdeacety-
lation of 92%), sodium alginate (Mw 300,000), was pur-
chased from Chengdu Ronghai Bio-Tech Development,
China.
Curcumin was purchased from Sigma-Aldrich Chemical
Co. (USA). All other reagents and solvents used were of
reagent grade.
2.2. Preparation of Chitosan-Alginate Sponge (CA sponge).
Chitosansolution(1.0%w/v)waspreparedbydissolvingchi-
tosan powder (0.2g) in 20ml of deionized water containing
acetic acid (1.0% by weight) at room temperature. Alginate
solution (1.0% by weight) was prepared by dissolving
sodiumalginatepowder(0.2g)in20mlofdeionizedwaterat
room temperature. The dissolved chitosan solution was then
added into the alginate solution (the chitosan-alginate blend
ratiosbyweightwere3:1,1:1and1:3)andblendedwithan
homogenizer (IKA T10, Germany) until an opaque aqueous
solution was obtained. The solution was centrifugated to
remove the trapped air bubbles. Then the air bubble-free
solution was poured into the wells of a 24-well plate (well
size: 17mm diameter, 20mm height) or a 6-well plate (well
size: 36mm diameter, 20mm height), frozen overnight at
−40◦C,andthenlyophilizedat−35◦Cfor24hoursinafreeze
dryer (VIRTIS Advantage wizard 2.0, USA).
2.3. Preparation of Curcumin-Loaded CA Sponge. Curcumin
was accurately weighed and dissolved in absolute ethanol.
The curcumin-ethanol solution was mixed with chitosan
solution. The mixed curcumin/chitosan solution was added
into the alginate solution and blended, centrifuged, frozen,
and lyophilized as described above.
2.4. Fourier Transform Infrared Spectroscopy (FTIR). The
characteristic absorption of chitosan-alginate interpolyelec-
trolyte complex, which ranged from 400 to 4000cm−1,w a s
recorded on a NICOLET 200SXV Infrared Spectrophotome-
ter (USA).
2.5. Morphology (SEM). The morphology of chitosan-
alginate sponge was investigated by scanning electron
microscopy (SEM, H-6009IV, Hitachi, Japan). Specimens
were cut and coated with gold. The sponge microstructures
were investigated by geometrical measurement on the scan-
ning electron micrographs.
2.6. Swelling Ability Study of Sponges. The swelling ability of
chitosan-alginate sponges was determined by incubating the
CA sponges in pH7.4 of phosphate buﬀer saline (PBS) at
roomtemperature.AknownweightofCAspongewasplaced
inthemedia.Thewetweightofthespongewasdeterminedat
requiredperiodoftimebyﬁrstblottingthespongewithﬁlter
papertoremoveadsorbedwateronthesurface,thenweighed
immediately on an electronic balance. The percentage water
adsorption of chitosan-alginate sponges in the media was
calculated as follows:
Esw =
(We −W0)
W0

×100, (1)
where Esw is the percentage water adsorption of chitosan-
alginatespongesatequilibrium.We denotestheweightofthe
chitosan-alginate sponges at equilibrium water adsorption,
and W0 is the initial weight of the chitosan-alginate sponges.
Each experiment was repeated 3 times, and the average value
was taken as the percentage water adsorption.
2.7. In Vitro Degradation. The chitosan-alginate sponges
were incubated at pH 7.4 in phosphate-buﬀered saline (PBS)
with 500–1000 U/C.C. of lysozyme concentration in 6-well
plate and kept at 37◦C. At required period of time, the
spongesweretakenout,washedwithdeionizedwater,frozen,
and lyophilized. The weights of the sponges were weight and
recorded:
Weight loss (%) =
(W0 −Wt)
W0

×100. (2)
2.8. Drug Loading and Release. Curcumin-incorporated CA
sponge was prepared by ﬁrst adding curcumin ethanol
solution (ﬁnal concentration was 1mg/ml in chitosan-
alginate solution) to chitosan solution under consequently
stirring. Then the mixed solution was added into alginate
solution, blended, centrifuged, frozen, and lyophilized as
described above.
Drug release experiments using 17mm-in-diameter
curcumin-incorporated CA sponges were conducted in 6
centrifuge tubes with 10ml phosphate-buﬀer solution (pH
4)withinashakerat37◦C.Allthesupernatantswerepipetted
outperiodicallyandreplacedwithequivalentvolumeoffresh
phosphate-buﬀer solution. The concentration of curcumin
was measured using HPLC (Waters, USA) at 420nm.
2.9. Wound Healing Test. The Sprague-Dawley (SD) rats
(160–180g, 6 weeks) were used in this wound healing test.
The animals were anaesthetized by using chloral hydrate
prior to the test. The dorsal hair of the rats was removed.
Full-thickness wound of 1.5 × 1.5cm 2 was excised from the
back of the rats. Each wound was covered with an equal size
of drug loaded sponge, or blank sponge, or cotton gauge
for comparison. On top of the wound dressings, a piece ofJournal of Biomedicine and Biotechnology 3
Tegaderm (3M,USA) wasapplied.Treatedratswereplaced
in individual cages, and the healing wounds were observed
on the 0th, 4th, and 12th days using a digital camera.
Skin wound tissue of rat was excised, ﬁxed with 10% for-
malin, and stained with hematoxylin-eosin (H&E) reagent
for histological observations.
3. Results andDiscussion
3.1. Preparation of Chitosan-Alginate Sponge and Curcumin-
Incorporated Chitosan-Alginate Sponge. The chitosan-
alginate sponges were successfully prepared in this work and
were shown in Figure 1(a).I nFigure 1(b), the sponge was
bent with forceps, which showed that this sponge is ﬂexible.
3.2. Fourier Transform Infrared Spectroscopy (FTIR). To
examine the chemical structures of various CA sponges
prepared under diﬀerent interpolyelectrolyte complex con-
ditions, the CA sponges were examined by FTIR spec-
tra. Figure 2 shows the FTIR spectrum from diﬀerent
chitosan/alginate blend ratios. The characteristic peak of
chitosan were seen at 1650 and 1590cm−1 correspond-
ing to amideand amino group. The alginate spectrum
shows characteristic band of carbonyl (C=O) band (1640
and 1424cm−1). The characteristic absorption of –NH3+
shifted to 1622 cm−1 in spectrums of three kinds of
sponges. The intensity of the characteristic peak order was
C2A2>C3A1>C1A3; this indicated that the degree of ionic
interaction between the negatively charged carboxylic ion
group of alginate and the positively charged amino group of
chitosan in three kinds of sponges was diﬀerent.
3.3. Morphology Study. The cross-section morphology of the
sponges is shown in Figure 3. Depending on the composi-
tion, there were clear diﬀerences in the appearance of the
ﬁbrillar structure of the sponges. As shown in Figures 3(a)
and 3(b), the pure alginate and chitosan showed a relatively
regular network. The pore sizes of the chitosan and alginate
are of approximately 200 and 100μm, respectively. The
mixture, however, as shown in Figures 3(c) and 3(d), showed
a much more irregular morphology. These diﬀerences may
be explained by that the mixed systems may have interacted
prior to the freezing and therefore would have already
formed a random ﬁbrillar network. However, the single
component system would have remained in solution; hence
the pore size is determined by ice crystal formation during
the freezing process. This may be reasonably expected to
be homogeneous throughout the sample, leading to a more
regular pore size and ﬁbrillar structure [6].
3.4. Water Uptake Ability. The water uptake ability of the
chitosan-alginate sponge was listed in Table 1. All the
sponges absorbed water within 30 seconds and were
saturated within 1 minute. The sponges with microporous
structures seem to show the diﬀerence in the water
adsorption depending on the porous structure, which is
attributed to the water retained within pores. From Table 1,
the water uptake of sponges decreased as we increased the
ratio of alginate to chitosan up to 3. This result should
depend on the pore structure. The C3A1 sponge can
(a)
(b)
Figure 1: Photograph of chitosan-alginate sponge (C2A2). (a)
Appearance (left, pure sponge; right, sponge with curcumin), (b)
sponge showing the pliability of the freeze dried material.
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Figure 2: FTIR spectra of various sponges.
Table 1: Water uptake ability of chitosan-alginate sponge.
Sponge type Mixing ratios Water uptake ability (%)
Chitosan Alginate
C3A1 3 1 4290
C2A2 2 2 3806
C1A3 1 3 1218
hold water in each pore surrounding by cell walls and
the water uptake ability reaches more than 4000%. The
C2A2 sponge decreased to 3806% because the ﬁbrous
networks contained in the sponge attenuate the ability of the
water retained within pores. On the other hand, the C1A3
sponge gave a smaller value of about 1000%, in which the4 Journal of Biomedicine and Biotechnology
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Figure 3: SEM micrographs of chitosan-alginate sponges: (a) alginate alone, (b) chitosan alone , (c) C2A2, and (d) Curcumin-C2A2.
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Figure 4: In vitro degradation of CA sponge in PBS lysozyme
solution.
pores are surrounded by the thin and fragile walls. The walls
might be comprised by a part of the unreacted alginate;
when the sponge was dropped into the water, the unreacted
alginate swelled and dissolved making the pore size increase
and therefore could not sustain much water within their
network structure. Another reason that might decrease the
water uptake ability of the sponge is the sealed-in cells. Water
can not get into the sealed-in cells resulting in a decrease in
the volume of water that can be held in the sponges.
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Figure 5:Theinvitroreleasebehaviorsofcurcuminfromchitosan-
alginate sponges.
3.5. In Vitro Degradation. To examine stability during a few
daysofcontactwiththewound,weexaminedstableproperty
of CA sponges. The percentage of weight loss of crosslinked
sponges as a function of degradation time is presented in
Figure 4. The weight loss for CS sponges ranges from 25% to
70%. Thespongespreparedwiththemixing ratio ofchitosan
to alginate of 1 : 3 showed 1.5–3 times higher weight loss
than that of 3 : 1 and 2 : 2. The order of the weight loss
was C1A3>C3A1>C2A2. The result indicated that the C2A2Journal of Biomedicine and Biotechnology 5
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Figure 6: Photographs of macroscopic appearance of wound repair covered with (a) cotton gauze as control, (b) C2A2 without curcumin,
and (c) C2A2 with curcumin, at day 0, day 4, and day 12, respectively.
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Figure 7: Total wound area of skin over time as a percentage of
original wound size.
sponge was more stable than the C3A1 and C1A3 sponges,
probably because crosslinking degree of C2A2 sponge was
stronger than the others, then was C3A1, and C1A3 was the
last one.
3.6. Drug Loading and Release. The release of curcumin
from sponge was investigated to evaluate its sustained ability.
Figure 5 shows the drug release behaviors of chitosan-
alginate sponges loaded with curcumin which was a
hydrophobic drug. In 20 days, about 50% and 70% of
the drug were released, respectively, from C2A2 and C3A1
sponge. While 80% of the drug within the C1A3 sponge
had been released in 3 days. This indicated that the C2A2
sponge has a better sustained release property than the C3A1
and C1A3 sponges. We thought that it can be attributed to
the interaction of amine groups on chitosan with carboxyl
groups on alginate. From the result of FTIR, we know that
theorderofionicinteractiondegreeofthreekindsofsponges
was C2A2>C3A1>C1A3. So the trapped drug in the C2A2
sponge released from the network structure was the slowest,
and that of C1A3 was the fastest.
3.7. Wound Healing Test. As the results of item 3.4–3.6,
we chose sponge C2A2 as our wound dressing in wound
healing test. In wound testing, full-thickness wounds were
made on the back of each rat (Figure 6). CA sponges with
or without drug were used to study wound healing behavior.
A sac o n t r o l ,t h ew o u n dw a sc o v e r e dw i t hc o t t o ng a u z e .
On the 4th postoperative day the cotton gauze adhered
to wound surface and removal of it resulted in the less of
tissue at the wound surface. The C2A2 and C2A2-Curcumin6 Journal of Biomedicine and Biotechnology
Control
(a)
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(b)
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Figure 8: The H&E stained sections of twelve-day postwounding (40×).
Control C2A2 C2A2-curcumin
(a)
Control C2A2 C2A2-curcumin
(b)
Figure 9: Masson’s Trichrome staining for collagen: (a) eight-day postwounding; (b) twelve-day postwounding (40×).
sponge also adhered to the wound surface and absorbed the
bleed and exudation at the wound site. We can see slight
bleeding and inﬂammation at the wound site when the C2A2
sponge peeled away, while the underlying granulation tissue
was formed in the case of C2A2-Curcumin sponge.
The wound on the 12th day was more contractive than
thewoundobservedonthe4thpostoperativeday;thehealing
of the C2A2 and C2A2-Curcumin sponges treated wound
was obviously faster than gauze-treated wound.
Figure 7showsthecontractionofthewoundtreatedwith
diﬀerent means. By observing the wound area at preset time,
the reduction in wound defect area was calculated. From
Figure 7, we could see a little diﬀerence between wound area
of three groups on the 4th postoperative. But by the 8th
day, the C2A2 and C2A2-Curcumin sponge-treated wounds
healed more quickly than the cotton gauze-treated wounds.
And the wound areas are almost half of the cotton gauze
treated wound area. On the 12th day, the C2A2 and C2A2-
Curcumin sponge-treated wounds contracted, respectively,
88% and 90%, whereas the control group contracted 74%.
Little diﬀerence was seen between the C2A2 and C2A2-
Curcumin sponge-treated wounds. This indicates that the
chitosan-alginate sponges with or without curcumin are all
suitable for a better wound healing eﬀect, and the wound
healing process seemed to mainly depend on the use of the
property of sponge itself. It suggested that the prepared CA
sponge could be a good material to be employed as wound
dressing.
3.8. Histological Examination. Figure 8 exhibits the histo-
logical results of three diﬀerent kinds of wound dressings
applied on the dorsal skin wound of SD rat. On the 12th
day, the dermis is still under the process of remodeling. The
gauze-treated wounds showed immature granulation tissue
with numerous inﬂammatory cells and congested vessels
(Figure 8(a)). However, the granulation tissue and collagen
alignment(Figures8(a)and8(b))wer emor eadvancedinthe
C2A2 sponge and C2A2-curcumin sponge-treated wounds
as compared to the gauze-treated wounds. And the vessel
numbers were smaller in the sponges-treated wound. These
twokindsofsponges-treatedwoundsdemonstratedcompact
and well-aligned collagen, showing that the wounds were
under a better healing environment.
The extent of collagen deposition in the wounds was
examined by Masson’s Trichrome staining. From Figure 9,Journal of Biomedicine and Biotechnology 7
we could see that gauze-treated wound had a loose reticular
arrangement of collagen, the space between the collagen
was relatively large, whereas collagen was relatively com-
pact, the bundles of collagen showed a better ordered
arrangement in the C2A2 sponge-treated wounds, and
the collagen content was greater than the former. The
C2A2-Curcumin sponge-treated wound also had a com-
pact and well-aligned arrangement of collagen, and the
bundles of collagen were thicker than both of the gauze
and the C2A2 sponge-treated wounds. This study showed
that the C2A2 sponge can promote the formation of the
collagen, thus accelerate the healing of wound. The use
of curcumin seemed to have a certain promoting eﬀect
on wound healing according to the collagen content and
arrangement.
4. Conclusions
In this work, the crosslinked sponges based on chitosan and
alginate were successfully prepared at the various conditions
of mixing ratios 3 : 1, 2 : 2, 1 : 3, and water uptake
ability ranging between 1000% and 4300%. Based on the
results of drug release of curcumin, we found that the
C2A2 sponges have a sustained release behavior for up
to 20 days. This shows that the C2A2 sponge could be a
good drug support to be employed for sustained release.
Based on the preliminary histological results on the 12th
postoperative days, the C2A2 and C2A2-Curcumin sponges
showed a better wound healing eﬀect in view of a rapid
contraction of wound, compared with the gauze-treated
wounds. Although no signiﬁcant diﬀerence of the reduction
in wound defect area was seen between the C2A2 and
C2A2-Curcumin sponges-treated wounds, a greater content
and a better arrangement of collagen in C2A2-Curcumin
sponges-treated wounds showed that adding curcumin into
the sponge has a certain promoting eﬀect on wound
healing.
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